pubmed-article:21195947 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0000726 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0524465 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0019243 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C1304680 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0540301 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C1261512 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
pubmed-article:21195947 | lifeskim:mentions | umls-concept:C0699795 | lld:lifeskim |
pubmed-article:21195947 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:21195947 | pubmed:dateCreated | 2011-1-3 | lld:pubmed |
pubmed-article:21195947 | pubmed:abstractText | hereditary angioedema (HAE) is a rare disorder characterized by a quantitative or functional deficiency of C1 esterase inhibitor (C1-INH), resulting in periodic attacks of acute edema at various body locations. The symptoms of these painful attacks can be treated effectively with C1-INH concentrate. | lld:pubmed |
pubmed-article:21195947 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195947 | pubmed:language | eng | lld:pubmed |
pubmed-article:21195947 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195947 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21195947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195947 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21195947 | pubmed:month | Jan | lld:pubmed |
pubmed-article:21195947 | pubmed:issn | 1534-4436 | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:BernsteinJona... | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:CraigTimothy... | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:KeineckeHeinz... | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:WassermanRich... | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:BewtraAgaindr... | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:HurewitzDavid... | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:LevyRobyn JRJ | lld:pubmed |
pubmed-article:21195947 | pubmed:author | pubmed-author:KiesslingPete... | lld:pubmed |
pubmed-article:21195947 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21195947 | pubmed:volume | 106 | lld:pubmed |
pubmed-article:21195947 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21195947 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21195947 | pubmed:pagination | 62-8 | lld:pubmed |
pubmed-article:21195947 | pubmed:dateRevised | 2011-5-17 | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:meshHeading | pubmed-meshheading:21195947... | lld:pubmed |
pubmed-article:21195947 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21195947 | pubmed:articleTitle | Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks. | lld:pubmed |
pubmed-article:21195947 | pubmed:affiliation | DallasAllergyImmunology, Dallas, Texas 75230, USA. richwasserman_pdai@yahoo.com | lld:pubmed |
pubmed-article:21195947 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21195947 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21195947 | lld:pubmed |